National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Fluoride toothpaste (Duraphat® 5,000 ppm)

Duraphat® 5,000ppm fluoride toothpaste is licensed for the prevention of dental caries in adolescents and adults, particularly amongst patients at risk from multiple caries (coronal and/or root caries).

 

NCPE Assessment Process Completed
Rapid review commissioned 30/07/2019
Rapid review completed 06/01/2020
Rapid Review outcome A full HTA is not recommended. The NCPE recommends that Duraphat® 5,000 ppm Fluoride toothpaste not be considered for reimbursement on the Community Drug Schemes. The NCPE recommend that Duraphat® 5000 ppm Fluoride toothpaste be reimbursed on an individual patient basis*.

 

*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods Act) 2013.